Taiwan · Delayed Price · Currency is TWD Andros Pharmaceuticals Co.,Ltd Company Description
Andros Pharmaceuticals Co.,Ltd, a biopharmaceutical company, engages in developing novel drug delivery platform technologies.
The company develops APC101, a fast-drying, film-forming, and meter-dosed spray, which is in Phase IIa clinical trial to treat pain associated with post-herpetic neuralgia; APC201, a novel dosage form of topical anesthetic that is in Phase I/II clinical trial for treatment of Osteoarthritis; and siRNA, an anti-sense oligonucleotide and DNA candidate.
Its preclinical phase products are APC310 and APC501 for anesthesia to intravenous catheter placement and venipuncture; and APC401, a special emulsified solution for anesthesia of post-surgery pain.
The company offers LALP cream for dermal analgesic applications; iMinos solution for Alopecia Androgenetica; and T4 endonuclease V.
Andros Pharmaceuticals Co.,Ltd was founded in 2008 and is based in Zhubei, Taiwan.
| Country | Taiwan |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: No. 22, Shengyi Road Zhubei, 30261 Taiwan | |
| Phone | 886 3 658 1866 |
| Website | andros.com.tw |
Stock Details
| Ticker Symbol | 6917 |
| Exchange | Taipei Exchange |
| Reporting Currency | TWD |
| ISIN Number | TW0006917008 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Ming-Wen Lee | Managerial Officer and Director |